685 US HIGHWAY ONE, NORTH BRUNSWICK, NJ
Approval of 2026 Equity Incentive Plan at Annual Meeting
Annual Report to Security Holders
Announces Second Quarter 2026 Financial Results
Financial Restatement Due to Misapplication of ASC 820
Investor Presentation
Pelthos Therapeutics Dismisses CBIZ as Independent Auditor
Announces First Quarter 2026 Financial Results
Reg. FD
Q2
Amended Quarterly Report
Q1
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
Definitive Merger Information Statement